News for Novavax, Inc. (NVAX.MX)

Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Novavax Inc. (NASDAQ:NVAX) is one of the best cheap stocks with huge upside potential. On June 11, BTIG maintained a Buy rating on Novavax Inc. (NASDAQ:NVAX) with a $19 price target. BTIG analyst Thomas Shrader told investors following the company’s announcement of the results of the initial cohort of its COVID-19-Influenza Combination and stand-alone trivalent hemagglutinin […]

Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to read an analysis of NVAX stock now.

Novavax Inc. (NASDAQ:NVAX) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On June 17, Citi initiated coverage of Novavax Inc. (NASDAQ:NVAX) with a Sell rating and a $6 price target. The firm acknowledged that vaccines are a “key cornerstone” to global health, and that Novavax Inc. (NASDAQ:NVAX) could contribute to the […]

Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.

Summary: Novavax (NVAX) faces a downturn after Citi issues a Sell rating with a $6 target. Despite recent challenges, Wall Street analysts project a sign

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Citi has begun its analysis of Novavax (NVAX) with a recommendation to sell, setting a target price of $6 for the stock. While acknowledging that vaccines play

Novavax, Inc. faces profitability challenges despite a promising tech platform, with uncertain revenue streams. Click for my NVAX stock update.

Novavax, Inc. (NASDAQ:NVAX) Goldman Sachs 46th Annual Global Healthcare Conference June 11, 2025 2:00 PM ETCompany ParticipantsJames Patrick Kelly -...

Health and Human Services Secretary Robert F. Kennedy Jr.’s decision to dismiss all 17 members of the ACIP has triggered a decline in shares of pharmaceutical companies like Novavax (NVAX), Pfizer (PFE), and Merck (MRK) in after-hours trading. Kennedy’s overhaul, aimed at restoring public trust in vaccine science, raises concerns…

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Novavax (NVAX) has experienced significant bullish options activity, with 15,477 call contracts traded, surpassing the expected volume by 10%. The implied volat

Summary Novavax Inc (NVAX), a biotechnology company known for its innovative vaccine solutions, announced on May 29, 2025, that it will participate in two signi

PR NewswireGAITHERSBURG, Md., May 29, 2025 GAITHERSBURG, Md., May 29, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will partic

Novavax (NVAX) to feature at Jefferies and Goldman Sachs investor conferences in June 2025. Live webcasts of events available, with replays accessible f

Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.

Market Analysis by covering: S&P 500, Novavax Inc, Sanofi ADR, Novo Nordisk A/S. Read 's Market Analysis on Investing.com